Transamerica Financial Advisors’s VanEck Biotech ETF BBH Stock Holding History

Transamerica Financial Advisors’s Portfolio BBH Stock Details BBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-406	Closed	-$67K	–	201
2020 Q2	$67K	Buy	+406	New	+$61.7K	0.01%	194

Other funds holding BBH

PAG

Pinnacle Advisory Group Columbia, Maryland $2.17B AUM 39.21% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

KAS

Kestra Advisory Services Austin, Texas $26.4B AUM 21.05% 1-Year Est. Return

MCM

Murphy Capital Management Bedminster, New Jersey $720M AUM 9.22% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

MJRIC

Mogy Joel R Investment Counsel Beverly Hills, California $1.75B AUM 17.81% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

Transamerica Financial Advisors's BBH Position: Q3 2020 in Review

Transamerica Financial Advisors sold out of VanEck Biotech ETF (BBH) in Q3 2020, closing a stake of 406 shares — an estimated $67K sold.

Transamerica Financial Advisors first reported a position in BBH in Q2 2020 and held it in 1 quarter. The position peaked at $67K in Q2 2020. 101 funds tracked by Wall St. Rank hold BBH as of Q3 2020.

Transamerica Financial Advisors reported no remaining VanEck Biotech ETF position as of Q3 2020 after selling out during the quarter.
Transamerica Financial Advisors sold 406 VanEck Biotech ETF shares in Q3 2020, an estimated $67K.
Transamerica Financial Advisors first reported a position in VanEck Biotech ETF in Q2 2020 and held it in 1 quarter.
Transamerica Financial Advisors's VanEck Biotech ETF position peaked at $67K in Q2 2020.
101 funds tracked by Wall St. Rank held VanEck Biotech ETF as of Q3 2020.

Based on Transamerica Financial Advisors's 13F filing for Q3 2020, filed 12 Nov 2020.